invasive breast cancer

Known as: Infiltrating Breast Carcinoma, breast cancer invasive, Invasive breast carcinoma 
Cancer that has spread from where it started in the breast into surrounding, healthy tissue. Most invasive breast cancers start in the ducts (tubes… (More)
National Institutes of Health

Related topics

Related topics

12 relations
AC-T RegimenBreastEpithelial CellsEpithelium
(More)

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2011
Highly Cited
2011
Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial.
CONTEXT Sentinel lymph node dissection (SLND) accurately identifies nodal metastasis of early breast cancer, but it is not clear… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?
Highly Cited
2007
Highly Cited
2007
Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based…
BACKGROUND Tumor markers are becoming increasingly important in breast cancer research because of their impact on prognosis… (More)
Is this relevant?
Highly Cited
2007
Highly Cited
2007
Prognostic markers in triple-negative breast cancer.
BACKGROUND Triple-negative breast cancer (estrogen receptor-negative, progesterone receptor-negative, and HER2-negative) is a… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
  • table 4
Is this relevant?
Highly Cited
2004
Highly Cited
2004
Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma.
PURPOSE Expression profiling studies classified breast carcinomas into estrogen receptor (ER)+/luminal, normal breast-like, HER2… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?
Highly Cited
2003
Highly Cited
2003
EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells.
The Polycomb Group Protein EZH2 is a transcriptional repressor involved in controlling cellular memory and has been linked to… (More)
Is this relevant?
Highly Cited
2003
Highly Cited
2003
Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial.
CONTEXT The Women's Health Initiative trial of combined estrogen plus progestin was stopped early when overall health risks… (More)
  • table 1
  • table 1
  • figure 1
  • figure 2
  • table 2
Is this relevant?
Highly Cited
2002
Highly Cited
2002
Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer.
BACKGROUND In 1976, we initiated a randomized trial to determine whether lumpectomy with or without radiation therapy was as… (More)
Is this relevant?
Highly Cited
2002
Highly Cited
2002
Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.
CONTEXT Despite decades of accumulated observational evidence, the balance of risks and benefits for hormone use in healthy… (More)
  • figure 1
  • table 1
  • table 1
  • figure 2
  • table 2
Is this relevant?
Highly Cited
1998
Highly Cited
1998
Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study.
BACKGROUND The finding of a decrease in contralateral breast cancer incidence following tamoxifen administration for adjuvant… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • table 3
Is this relevant?
Highly Cited
1991
Highly Cited
1991
Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma.
BACKGROUND Experimental evidence suggests that the growth of a tumor beyond a certain size requires angiogenesis, which may also… (More)
Is this relevant?